ARKG vs DMRI
ARKG vs DMRI
ARK Genomic Revolution ETF vs DeltaShares(R) S&P International Managed Risk ETF
Quick Verdict
ARKG offers more diversification with 31 holdings.
Lower Fees: TiedHigher Returns: TiedMore Diversified: ARKG
Side-by-Side Comparison
| Metric | ARKG | DMRI | Winner |
|---|---|---|---|
| Expense Ratio | 0.75% | - | |
| AUM | $1.6B | - | |
| Dividend Yield | 0.00% | - | |
| Holdings | 33 | 0 | |
| YTD Return | +51.88% | - | |
| 1Y Return | +76.15% | - | |
| 3Y Return (annualized) | +11.66% | - | |
| 5Y Return (annualized) | -11.51% | - | |
| Volatility (annualized) | 36.4% | - | |
| Max Drawdown | -83.6% | - | |
| Fund Family | Ark Invest | Transamerica ETF Trust | |
| Category | Equity | - | |
| Inception | Oct 31, 2014 | - |
ARKG vs DMRI Performance
ARK Genomic Revolution ETF (ARKG) is a ETF from Ark Invest and DeltaShares(R) S&P International Managed Risk ETF (DMRI) is a ETF from Transamerica ETF Trust.
Risk: Volatility and Drawdowns
Frequently Asked Questions
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.